China: Compliance Processes for Life Science Products

A RAPS pre-approved webinar on the topic, “China: Compliance Processes for Life Science Products: Company Establishment, Clinical Trials, Registrations, Renewals and Supply Chain Considerations” is being held on September 11 by GlobalCompliancePanel.

Online PR News – 24-August-2012 – Wilmington – Summary:A RAPS pre-approved webinar on the topic, “China: Compliance Processes for Life Science Products: Company Establishment, Clinical Trials, Registrations, Renewals and Supply Chain Considerations” is being held on September 11 by GlobalCompliancePanel, a leading regulatory and compliance continuing education training provider. This webinar earns 1.5 RAC credits towards a participant's RAC recertification upon full completion. The speaker of this 90-minute webinar will be Robert J. Russell, President of RJR Consulting.
-----------------------------------------------------------------------------------------------------------------
Description:
The common belief is that China, among the world's fastest growing economies, is a manufacturing-dependent economy. However,China offers enormous opportunities in the life sciences, Pharmaceuticals, Medical Devices, Biologics and Combination Products markets too, an area in which it has been growing appreciably in the past few years.
In tune with this growth, China has been updating and improving its regulatory regime governing the food and pharmaceutical industry. A prominent action China took of late has been the 2010 amendment ofGMP, GLP, GCP, GSP and other regulations. With this, China has started getting closer to international standards of practice.
It is both necessary and important for manufacturers and distributors of drugs and medical devices interested in China, to pay close attention to the pace at which SFDA implements these changes and make changes to their standard operating procedures when necessary, if they are to ensure compliance with the evolving regime.
These are what this webinar will address. It will specifically focus on the overall regulatory compliance requirements and procedures for Pharmaceuticals, Medical Devices, Biologics and Combination Products in China.
-----------------------------------------------------------------------------------------------------------------
When:September 11, 10:00 AM PDT | 01:00 PM EDT
-----------------------------------------------------------------------------------------------------------------
By whom:For the past 9 years, Bob has been President of RJR Consulting, Inc. The company assists the pharmaceutical, medical device and biotech industries in understanding and complying with International Regulations affecting compliance, new product development, manufacturing and quality assurance. RJR has offices in Columbus, OH, Washington DC, and Brussels, Belgium with exclusive affiliates across Asia and Latin America.
Bob has 28 years of past industry experience as a CMC specialist, R&D Director and Global Director of Regulatory Affairs for Merion Merrill Dow pharmaceuticals and Cordis-Dow medical devices. He has a BS/MS degree in Chemistry.
-----------------------------------------------------------------------------------------------------------------
For whom:
The webinar will benefit
o QA/QC/Compliance/Regulatory Affairs
o Marketing & Sales & Customer Service
o Engineering/Technical Services
o Consultants
o Operations and Manufacturing
----------------------------------------------------------------------------------------------------------------
Duration: 90 minutes
-----------------------------------------------------------------------------------------------------------------
To enroll for this webinar, contact
webinars@globalcompliancepanel.com
Phone: 800-447-9407

Bookmarkse-mailGoogledel.icio.usStumbleUponSlashdotFurlDiggTechnoratiYahooMyWebBlinkListSpurlRawSugarWists
 
 
Contact Information
Webinar Web
http://www.globalcompliancepanel.com
Wilmington Delaware, 19801
8004479407